Denosumab injection (Prolia, Xgeva)

Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis

Thinking about stopping Prolia or bisphosphonates? A lot of people get told they can’t, but here’s the real scoop. These meds slow bone breakdown, and stopping (especially Prolia) can trigger a temporary surge in bone turnover, which can mean a window of faster bone loss if it’s not managed with a strategy. Coming off isn’t impossible, but it shouldn’t be a solo mission. The best transitions include your clinician, smart timing, and follow ups on bone turnover markers, plus solid hormones, nutri

Bisphosphonates, raloxifene, denosumab, calcitonin - Free Sketchy Medical Lesson